Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 6;23(11):71.
doi: 10.1007/s11920-021-01284-2.

Obsessive-Compulsive Disorder During the COVID-19 Pandemic: a Systematic Review

Affiliations

Obsessive-Compulsive Disorder During the COVID-19 Pandemic: a Systematic Review

Andrew G Guzick et al. Curr Psychiatry Rep. .

Abstract

Purpose of review: This systematic review evaluated the impact of the COVID-19 pandemic on obsessive-compulsive symptoms.

Recent findings: Most studies showed that obsessive-compulsive symptoms worsened during the early stages of the pandemic, particularly for individuals with contamination-related obsessive-compulsive disorder (OCD), though other symptoms dimensions were found to worsen as well. Many patients and individuals in the general population experienced new obsessive-compulsive-like symptoms centered on COVID-19. Self-reported rates of symptom exacerbation and COVID-19-focused symptoms were consistently lower in studies that recruited patients from specialty clinics (compared to online samples). Most studies were conducted in Spring/Summer, 2020. The COVID-19 pandemic has been an enormous stressor for individuals with OCD, especially for those with contamination symptoms. Regardless, there is strong reason to believe gold standard treatment approaches for OCD have maintained strong efficacy. Disseminating and effectively delivering evidence-based treatments for OCD is an urgent public health priority.

Keywords: Cognitive-behavioral therapy; Contamination; Exposure and response prevention; OCD; Serotonin reuptake inhibitors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PRISMA 2020 flow diagram: OCD and COVID-19. From: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. https://doi.org/10.1136/bmj.n71. For more information, visit: http://www.prisma-statement.org/

References

    1. Banerjee DD. The other side of COVID-19: impact on obsessive compulsive disorder (OCD) and hoarding. Psychiatry Res. 2020;288:112966. - PMC - PubMed
    1. Storch EA, Schneider SC, Guzick A, McKay D, Goodman WK. Impact of COVID-19 on exposure and response prevention for obsessive-compulsive disorder: present and post-pandemic considerations. Psychiatry Res. 2020;292:113310. - PMC - PubMed
    1. Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry. 2008;165(12):1532–42. - PMC - PubMed
    1. French I, Lyne J. Acute exacerbation of OCD symptoms precipitated by media reports of COVID-19. Ir J Psychol Med. 2020;37(4):291–4. - PMC - PubMed
    1. Davide P. The impact of the COVID-19 pandemic on patients with OCD: effects of contamination symptoms and remission state before the quarantine in a preliminary naturalistic study. Psychiatry Res. 2020;291:113213. doi: 10.1016/j.psychres.2020.113213. - DOI - PMC - PubMed

Publication types